Recent Coverage

 

May 18, 2015

The Washington Post
Stem cell ‘Wild West’ takes root amid lack of US regulation
Business | By Matthew Perrone | AP May 18, 2015 BEVERLY HILLS, Calif. — The liquid is dark red, a mixture of fat and blood, and... Read full article

May 14, 2015

Injured Athletes Could get Back in the Game Putting New Cells to Work on old Injuries
Clinical trials underway for chronic Achilles tendinosis By: Tammey George Being sidelined due to an injury puts a tremendous amount of pressure on an athlete... Read full article

May 12, 2015

Impact Magazine: Aching Achilles?
Regenerative Medicine Promises New Cure for Chronic Tendon Injuries By Dr. Jack Taunton A Regerative Cell therapy is now being tested on people suffering... Read full article

May 11, 2015

The Province: UBC achilles research could be key to revolutionary treatment
University studying the injection of cultivated cells from one’s own body to speed the healing process By Tony Gallagher, The Province May 9, 2015... Read full article

May 4, 2015

Stockhouse: Tech Roundup – RepliCel (V.RP) grows, SoMedia (V.VID) profits, WiLAN (WILN) flounders
By: Gaalen Engen First here’s a little biotech. RepliCel Life Sciences (TSX: V.RP, Stock Forum) has been a little favourite of mine for the past while as... Read full article

April 27, 2015

Japan’s Take on Regenerative Medicine: Early Commercialization, Early Reimbursement
By Gail Dutton, Contributing Editor Follow Me On Twitter @GailLdutton New regulations accelerating the approval of regenerative therapeutics in Japan took effect Nov. 25,... Read full article

April 24, 2015

How to Grow a Regenerative Medicine Industry in Canada: Michael May of CCRM
Source: George S. Mack of The Life Sciences Report  (4/23/15) There’s a new kind of incubator in town. The Centre for Commercialization of Regenerative Medicine... Read full article

April 15, 2015

Cell Therapy is “Hair Raising” in a Good Way
RepliCel Targets Low-Risk, Near-Term Opportunities in Regenerative Medicine By: Gail Dutton The regenerative medicine company RepliCel Life Sciences is developing potential cures for chronic... Read full article

March 19, 2015

The Life Sciences Report: Will Stem Cell Profits Measure Up?
To read the article on The Life Sciences Report, click here: It makes no sense to look at stem cell companies differently from drug... Read full article

March 16, 2015

Stockhouse: RepliCel Hits Lucrative Bio-med Trifecta with Innovative Tech
To read the article on Stockhouse click here Until 2011, RepliCel Life Sciences (TSX: V.RP, Stock Forum) was engaged in the business of hair... Read full article